Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age
Clinical trial NCT02242643 · COMPLETED
Trial details
- NCT number
- NCT02242643
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-03-16
- Enrollment
- 2432
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.